Sponsored Links
| Study Supports Safety Profile Of Diagnostic Heart Ultrasound Contrast Agent Optison |
 |
 |
 |
| Medical News - Cardiovascular and Cardiology | |||
|
GE Healthcare Medical Diagnostics has announced results of a study that evaluated the cardiopulmonary safety of Optison™ (Perflutren Protein-Type A Microspheres Injectable Suspension, USP), a diagnostic ultrasound contrast agent for use in improving suboptimal echocardiograms... Read more: Cardiovascular / Cardiology News From Medical News Today
|